Innoviva Inc (INVA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 35 US Dollar | 4 | 0 | 0 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 72.245.485 | 13,66 | 7,44 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Innoviva Inc
Mitarbeiter 159
Handelsplatz NASDAQ
Ticker Symbol INVA
IPO Datum 2004-10-05
Adresse 1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
Webseite https://www.inva.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Pavel Raifeld C.F.A. | CEO & Director |
| 2 | Mr. Stephen Basso M.B.A. | Chief Financial Officer |
| 3 | Ms. Marianne Zhen CPA | Chief Accounting Officer & Secretary |
| 4 | Ms. Patricia M. Drake | Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc. |
| 5 | Dr. David Altarac M.D., MPA | Chief Medical Officer of IST |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 15,99% | 0,24 Mrd. USD |
| 2 | Dimensional Fund Advisors, Inc. | 6,22% | 0,10 Mrd. USD |
| 3 | Vanguard Portfolio Management, LLC | 5,84% | 0,09 Mrd. USD |
| 4 | Renaissance Technologies Corp | 5,59% | 0,09 Mrd. USD |
| 5 | State Street Corp | 4,52% | 0,07 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,37% | 0,07 Mrd. USD |
| 7 | Millennium Management LLC | 3,52% | 0,05 Mrd. USD |
| 8 | Geode Capital Management, LLC | 2,87% | 0,04 Mrd. USD |
| 9 | Systematic Financial Management LP | 2,80% | 0,04 Mrd. USD |
| 10 | Boston Partners Global Investors, Inc | 2,67% | 0,04 Mrd. USD |
| 11 | Sarissa Capital Management LP | 2,62% | 0,04 Mrd. USD |
| 12 | Bank of America Corp | 2,31% | 0,04 Mrd. USD |
| 13 | The Goldman Sachs Group Inc | 2,24% | 0,03 Mrd. USD |
| 14 | American Century Companies Inc | 2,07% | 0,03 Mrd. USD |
| 15 | Marshall Wace Asset Management Ltd | 2,01% | 0,03 Mrd. USD |
| 16 | Morgan Stanley - Brokerage Accounts | 1,69% | 0,03 Mrd. USD |
| 17 | Royce & Associates, LP | 1,62% | 0,03 Mrd. USD |
| 18 | Charles Schwab Investment Management Inc | 1,59% | 0,02 Mrd. USD |
| 19 | Two Sigma Investments LLC | 1,43% | 0,02 Mrd. USD |
| 20 | Qube Research & Technologies | 1,35% | 0,02 Mrd. USD |